Magnetic Field-Enhanced Agglutination Readout Combined With Isothermal Reverse Transcription Recombinase Polymerase Amplification for Rapid and Sensitive Molecular Detection of Dengue Virus.

RT-RPA dengue innovative diagnostic magnetic field-enhanced agglutination magnetic nanoparticles

Journal

Frontiers in chemistry
ISSN: 2296-2646
Titre abrégé: Front Chem
Pays: Switzerland
ID NLM: 101627988

Informations de publication

Date de publication:
2021
Historique:
received: 17 11 2021
accepted: 24 12 2021
entrez: 10 2 2022
pubmed: 11 2 2022
medline: 11 2 2022
Statut: epublish

Résumé

Among the numerous molecular diagnostic methods, isothermal reverse transcription recombinase polymerase amplification (RT-RPA) is a simple method that has high sensitivity and avoids the use of expensive instruments. However, detection of amplified genomes often requires a fluorescence readout on costly readers or migration on a lateral flow strip with a subjective visual reading. Aiming to establish a new approach to rapidly and sensitively detect viruses, we combined RT-RPA with a magnetic field-enhanced agglutination (MFEA) assay and assessed the ability of this method to detect the dengue virus (DENV). Magnetization cycles accelerated the capture of amplified DENV genomes between functionalized magnetic nanoparticles by a fast chaining process to less than 5 min; the agglutination was quantified by simple turbidimetry. A total of 37 DENV RNA

Identifiants

pubmed: 35141206
doi: 10.3389/fchem.2021.817246
pii: 817246
pmc: PMC8819590
doi:

Types de publication

Journal Article

Langues

eng

Pagination

817246

Informations de copyright

Copyright © 2022 Leon, Pinchon, Mayran, Daynès, Morvan, Molès, Cantaloube and Fournier-Wirth.

Déclaration de conflit d'intérêts

AD is an employee of HORIBA Medical. FL, EP, CM, AD, J-PM, J-FC, and CF-W are coinventors of patent PCT/FR2021/000022 (Detection of infectious agents based on recombinase polymerase amplification combined with magnetic field-enhanced agglutination). The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling Editor declared a past co-authorship with one of the authors (CF). The authors declare that this study received funding from HORIBA Medical, Etablissement Français du Sang (EFS), and by the University of Montpellier and its I-SITE MUSE Program (ArboMag project) funded by the french government. HORIBA Medical funder had the following involvement in the study: i) AD is a company employee with expertise on magnetic agglutination, ii) the prototype platform for magnetic field-enhanced agglutination is provided by the company.

Références

PLoS One. 2015 Jun 15;10(6):e0129682
pubmed: 26075598
Sci Transl Med. 2020 Jan 29;12(528):
pubmed: 31996463
Lancet Infect Dis. 2018 Nov;18(11):e355-e361
pubmed: 29934112
Mol Cell Probes. 2019 Aug;46:101413
pubmed: 31202830
J Clin Microbiol. 2005 Jun;43(6):2895-903
pubmed: 15956414
Talanta. 2020 Nov 1;219:121344
pubmed: 32887073
Front Bioeng Biotechnol. 2020 Feb 20;8:102
pubmed: 32154233
PLoS One. 2021 Apr 1;16(4):e0249602
pubmed: 33793682
Int J Infect Dis. 2020 Oct;99:193-198
pubmed: 32659449
Int J Infect Dis. 2020 Jun;95:406-412
pubmed: 32272263
Stat Med. 1998 Apr 30;17(8):857-72
pubmed: 9595616
PLoS Biol. 2006 Jul;4(7):e204
pubmed: 16756388
Anal Chem. 2013 Oct 1;85(19):9204-12
pubmed: 24050654
BMJ Glob Health. 2019 Jan 29;4(Suppl 2):e001179
pubmed: 30815287
Nat Rev Dis Primers. 2016 Aug 18;2:16055
pubmed: 27534439
Microorganisms. 2021 Mar 24;9(4):
pubmed: 33805173
Analyst. 2018 Dec 17;144(1):31-67
pubmed: 30426974
BMC Infect Dis. 2013 Aug 21;13:387
pubmed: 23964963
PLoS Negl Trop Dis. 2018 May 29;12(5):e0006381
pubmed: 29813062
J Clin Microbiol. 2015 Mar;53(3):830-7
pubmed: 25568438
Talanta. 2018 Dec 1;190:391-396
pubmed: 30172524

Auteurs

Fanny Leon (F)

Pathogénèse et Contrôle des Infections Chroniques et Emergentes, Université de Montpellier, Etablissement Français du Sang, Inserm, Université des Antilles, Montpellier, France.

Elena Pinchon (E)

Pathogénèse et Contrôle des Infections Chroniques et Emergentes, Université de Montpellier, Etablissement Français du Sang, Inserm, Université des Antilles, Montpellier, France.

Charly Mayran (C)

Pathogénèse et Contrôle des Infections Chroniques et Emergentes, Université de Montpellier, Etablissement Français du Sang, Inserm, Université des Antilles, Montpellier, France.

Aurélien Daynès (A)

HORIBA Medical, Montpellier, France.

François Morvan (F)

Institut des Biomolecules Max Mousseron (IBMM), Université de Montpellier, CNRS, ENSCM, Montpellier, France.

Jean-Pierre Molès (JP)

Pathogénèse et Contrôle des Infections Chroniques et Emergentes, Université de Montpellier, Etablissement Français du Sang, Inserm, Université des Antilles, Montpellier, France.

Jean-François Cantaloube (JF)

Pathogénèse et Contrôle des Infections Chroniques et Emergentes, Université de Montpellier, Etablissement Français du Sang, Inserm, Université des Antilles, Montpellier, France.

Chantal Fournier-Wirth (C)

Pathogénèse et Contrôle des Infections Chroniques et Emergentes, Université de Montpellier, Etablissement Français du Sang, Inserm, Université des Antilles, Montpellier, France.

Classifications MeSH